Neurological side effects of amiodarone Review article

Article Sidebar

Requires Subscription PDF (Język Polski)


Published: Mar 31, 2013
Keywords:
amiodaron, side effects, central and peripheral nervous system

Main Article Content

Marta Lipowska
Klinika Neurologii, I Wydział Lekarski, Warszawski Uniwersytet Medyczny
Andrzej Opuchlik
Klinika Neurologii, I Wydział Lekarski, Warszawski Uniwersytet Medyczny
Marek Postuła
1. Klinika Kardiologii Zachowawczej i Nadciśnienia Tętniczego, Centralny Szpital Kliniczny MSW w Warszawie. 2. Katedra i Zakład Farmakologii Klinicznej i Doświadczalnej, Warszawski Uniwersytet Medyczny
Dariusz A. Kosior
1. Klinika Kardiologii Zachowawczej i Nadciśnienia Tętniczego, Centralny Szpital Kliniczny MSW w Warszawie. 2. Wydział Nauk o Zdrowiu, Uniwersytet im. Kazimierza Pułaskiego w Radomiu

Abstract

Neurological side effects of amiodarone are not infrequent and are typically found in 20–40% patients treated. Both central and peripheral neurological side effects can be present and majority of them are related to long term high dose oral treatment. Management of these side effects is focused on symptomatic treatment. In order to minimize the side effects lowering the dose or even discontinuing of the drug may be necessary.

Downloads

Download data is not yet available.

Article Details

How to Cite
Lipowska , M., Opuchlik , A., Postuła , M., & Kosior , D. A. (2013). Neurological side effects of amiodarone. Cardiology in Practice, 7(1), 13-16. Retrieved from https://journalsmededu.pl/index.php/kwp/article/view/1573
Issue
Vol 7 No 1 (2013)
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

References

1. Physicians’ Desk Reference. Wyd. 57. Thomson PDR at Montvale, 2003: 3384-3390.
2. Charness M.E., Morady F., Scheinman M.M.: Frequent neurologic toxicity associated with amiodaron therapy. Neurology 1984; 34: 669-671.
3. Martinez-Arizala A., Sobol S.M., McCarty G.E. et al.: Amiodarone neuropathy. Neurology 1983; 33: 643-645.
4. Palakurthy P.R., Iyer V., Meckler R.J.: Unusual neurotoxicity associated with amiodarone therapy. Arch. Intern. Med. 1987; 147(5): 881-884.
5. LeQuesne P.M.: Neuropathy due to drugs. W: Peripheral Neuropathy. Dyck P.J., Thomas P.K., Griffin J.W. et al. (red.). WB Saunders, Philadelphia 1993: 1571-1572.
6. Wilson J.S., Podrid P.J.: Side effects from amiodarone. Am. Heart J. 1991; 121:158-171.
7. Fikkers B.G., Bogousslavsky J., Regli F. et al.: Pseudotumor cerebri with amiodarone. J. Neurol. Neurosurg. Psychiatry 1986; 49(5): 606-608.
8. Hugon J., Vallat J.M., Dumas M. et al.: Myeloneuropathy, neurologic toxicity, and amiodarone. Neurology 1985; 35: 282.
9. Manyam B.V.: Uncommon forms of tremor. W: Movement disorders. Watts R.L., Koller W.C. (red.). McGraw-Hill, New York 1997: 387-404.
10. Hubble J.P.: Drug-induced parkinsonism. W: Movement disorders. Watts R.L., Koller W.C. (red.). McGraw-Hill, New York 1997: 325-330.
11. Vorperian V.R., Havighurst T.C., Miller S. et al.: Adverse effects of low dose amiodarone: a meta-analysis. J. Am. Coll. Cardiol. 1997; 30: 791-798.